Clinical Trials Logo

Clinical Trial Summary

The usability of a novel test to categorize a distorted visual impression (metamorphopsia) is examined with the questionnaire "SUS"


Clinical Trial Description

Introduction Diseases of the retinal centre (macula) can lead to a distorted visual impression (metamorphopsia). The usability of a novel on-screen test to categorize metamorphopsia is to be examined with the questionnaire "SUS" to determine how user-friendly the software is perceived. Purpose To examine the usability of the software for persons perceiving metamorphopsia employing the questionnaire SUS. Aim of the work Improvement of the software in terms of user-friendliness. Methods For this observational pilot study, 30 persons are to be recruited from the patient pool of a private practice. Primary endpoint: Score of the SUS questionnaire. Each participating person performs the test once with each eye wearing appropriate near correction. The test shows on a screen 4 square fields with a grid pattern of horizontal and vertical lines. All 4 fields have lines that are partially distorted. The task of the test person is to select the field with more distinctively distorted lines when viewed with one eye.This selection must be made at least 10 times per eye: an algorithm determines the smallest correctly named distortion difference. Afterwards each person answers the System Usability Scale (SUS) questionnaire, SUS contains five positive and five negative statements on the usability of the system being evaluated. For each statement, the study participant gives his or her approval or rejection in the form of a scale ranging from 1= "strong approval" to 5= "strong rejection" of the statement. The results of the SUS questionnaire are used to calculate a numerical value (SUS score). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04347564
Study type Observational
Source Augenheilkunde Lindenthal
Contact
Status Completed
Phase
Start date May 4, 2020
Completion date September 30, 2020

See also
  Status Clinical Trial Phase
Active, not recruiting NCT03872479 - Single Ascending Dose Study in Participants With LCA10 Phase 1/Phase 2
Active, not recruiting NCT02595502 - Clinical Evaluation of Two Silicone Hydrogel Daily Disposable Contact Lenses N/A
Completed NCT02485054 - A Predictive Score for the Ischemic Etiology of a Transient Visual Disturbances (VASCO)
Completed NCT00985231 - Performance Evaluation of Contact Lenses Among a Population of Adapted Contact Lens Wearers N/A
Recruiting NCT05208658 - Characteristics of the Vergence Responses of Binocularly Normal Subjects After a Vision Therapy Protocol N/A
Recruiting NCT06077682 - Cycloplegic Refraction in Pediatric Patients With Esotropia Phase 4
Active, not recruiting NCT04123626 - A Study to Evaluate the Safety and Tolerability of QR-1123 in Subjects With Autosomal Dominant Retinitis Pigmentosa Due to the P23H Mutation in the RHO Gene Phase 1/Phase 2
Recruiting NCT04693247 - Handheld Device Compared With a Standard Eye Care Diagnostic Device in Measuring Ophthalmic Refraction N/A
Recruiting NCT06451172 - Novel Antisense Oligonucleotide Eye Drops for Treating Antibiotic-Resistant Bacterial Keratitis Early Phase 1
Completed NCT01318577 - Study of A New Contact Lens Cleaning and Disinfecting Solution N/A
Completed NCT03763721 - The ADVISE Study: Advanced Visualization In Corneal Surgery Evaluation N/A
Completed NCT05602402 - To Evaluate the Efficacy and Safety of CAEP-01 on Eye Strain in Children With Heavy Screen Use N/A
Not yet recruiting NCT06085430 - Kubota Glass Parameter Refinement Study N/A
Completed NCT01698788 - Effect of Intraoperative Dexamethasone Implant in Taut Posterior Hyaloid Removal in Diabetic Macular Edema N/A
Completed NCT01546402 - Intraoperative Dexamethasone Implant Improves Outcome of Cataract Surgery With Diabetic Macular Edema Phase 4
Completed NCT03169855 - Validation of Mesopic and Photopic Contrast Vision Tests With Respect to Nighttime Driving Ability
Terminated NCT03913130 - Extension Study to Study PQ-110-001 (NCT03140969) Phase 1/Phase 2
Recruiting NCT03479021 - SPOT Vision Screening
Recruiting NCT05600140 - Viewing Strategy Training in Children With (Cerebral) Visual Impairment N/A
Completed NCT03780257 - Study to Evaluate Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene Phase 1/Phase 2